Skip to main content

Table 2 Time-Updated Metabolic Labs and Breast Cancer Survival in Women With Stage I-III Breast Cancer (N = 13,434)

From: Metabolic abnormalities and survival among patients with non-metastatic breast cancer

Characteristic

Model*

HR1

95% CI1

p-value

Glucose2

 Low (< 60)

5.29

2.17, 12.9

< 0.001

 High (> 99)

1.19

1.03, 1.37

0.019

HDL2

 Low (≤ 45)

1.77

1.53, 2.05

< 0.001

LDL2

 High (≥ 129)

0.91

0.79, 1.05

0.2

Triglycerides2

 High (≥ 199)

0.99

0.82, 1.20

> 0.9

  1. 1HR = Hazard Ratio, CI Confidence Interval
  2. 2All labs measured in mg/dL; all reference levels are normal
  3. *Model adjusted for age at diagnosis, race/ethnicity, stage at diagnosis, ER and HER2 status, receipt of chemotherapy, and time-updated metabolic labs, body mass index, diabetes, tamoxifen and aromatase inhibitors, and dyslipidemia medications
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us